Loading…
Synthesis and evaluation of acylguanidine FXa inhibitors
A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compoun...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2008-08, Vol.18 (16), p.4696-4699 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03 |
---|---|
cites | cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03 |
container_end_page | 4699 |
container_issue | 16 |
container_start_page | 4696 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 18 |
creator | O’Connor, Stephen P. Atwal, Karnail Li, Chi Liu, Eddie C.-K. Seiler, Steven M. Shi, Mengxiao Shi, Yan Stein, Philip D. Wang, Ying |
description | A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is
1 with a FXa IC
50 of 6
nM. |
doi_str_mv | 10.1016/j.bmcl.2008.07.004 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19331450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X08007713</els_id><sourcerecordid>19331450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</originalsourceid><addsrcrecordid>eNp9kE9LxDAQR4Mouq5-AQ_Si95aJ202TcGLLP6DBQ8qeAvTZKpZuqkmrbDf3i676M3TXN77MTzGzjhkHLi8Wmb1yrRZDqAyKDMAsccmXEiRFgJm-2wClYRUVeLtiB3HuATgAoQ4ZEdcSSHKPJ8w9bz2_QdFFxP0NqFvbAfsXeeTrknQrNv3Ab2zzlNy94aJ8x-udn0X4gk7aLCNdLq7U_Z6d_syf0gXT_eP85tFaoTifcotklXGVMpWaPPKlkj1rKytNGCKUnGZF42yVsqmKHghydRYibIoCTlvGiim7HK7-xm6r4Fir1cuGmpb9NQNUfNq9MRsA-Zb0IQuxkCN_gxuhWGtOehNL73Um15600tDqcdeo3S-Wx_qFdk_ZRdoBC52AEaDbRPQGxd_uRwkKJlXI3e95Whs8e0o6GgceUPWBTK9tp37748fUeWJPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19331450</pqid></control><display><type>article</type><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><source>ScienceDirect Journals</source><creator>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</creator><creatorcontrib>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</creatorcontrib><description>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is
1 with a FXa IC
50 of 6
nM.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3405</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmcl.2008.07.004</identifier><identifier>PMID: 18644722</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Anticoagulants - chemical synthesis ; Anticoagulants - pharmacology ; Antithrombin III - chemical synthesis ; Antithrombin III - pharmacology ; Biological and medical sciences ; Blood Coagulation ; Blood. Blood coagulation. Reticuloendothelial system ; Carboxylic Acids - chemistry ; Chemistry, Pharmaceutical - methods ; Coagulation ; Drug Design ; Factor Xa ; Factor Xa - chemistry ; Guanidines - chemical synthesis ; Guanidines - pharmacology ; Guanine - chemistry ; Humans ; Imidazoles - chemistry ; Inhibitory Concentration 50 ; Medical sciences ; Models, Chemical ; Molecular Structure ; Pharmacology. Drug treatments ; Serine protease</subject><ispartof>Bioorganic & medicinal chemistry, 2008-08, Vol.18 (16), p.4696-4699</ispartof><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</citedby><cites>FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20608629$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18644722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O’Connor, Stephen P.</creatorcontrib><creatorcontrib>Atwal, Karnail</creatorcontrib><creatorcontrib>Li, Chi</creatorcontrib><creatorcontrib>Liu, Eddie C.-K.</creatorcontrib><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Shi, Mengxiao</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Stein, Philip D.</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is
1 with a FXa IC
50 of 6
nM.</description><subject>Anticoagulants - chemical synthesis</subject><subject>Anticoagulants - pharmacology</subject><subject>Antithrombin III - chemical synthesis</subject><subject>Antithrombin III - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Carboxylic Acids - chemistry</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Coagulation</subject><subject>Drug Design</subject><subject>Factor Xa</subject><subject>Factor Xa - chemistry</subject><subject>Guanidines - chemical synthesis</subject><subject>Guanidines - pharmacology</subject><subject>Guanine - chemistry</subject><subject>Humans</subject><subject>Imidazoles - chemistry</subject><subject>Inhibitory Concentration 50</subject><subject>Medical sciences</subject><subject>Models, Chemical</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Serine protease</subject><issn>0960-894X</issn><issn>0968-0896</issn><issn>1464-3405</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LxDAQR4Mouq5-AQ_Si95aJ202TcGLLP6DBQ8qeAvTZKpZuqkmrbDf3i676M3TXN77MTzGzjhkHLi8Wmb1yrRZDqAyKDMAsccmXEiRFgJm-2wClYRUVeLtiB3HuATgAoQ4ZEdcSSHKPJ8w9bz2_QdFFxP0NqFvbAfsXeeTrknQrNv3Ab2zzlNy94aJ8x-udn0X4gk7aLCNdLq7U_Z6d_syf0gXT_eP85tFaoTifcotklXGVMpWaPPKlkj1rKytNGCKUnGZF42yVsqmKHghydRYibIoCTlvGiim7HK7-xm6r4Fir1cuGmpb9NQNUfNq9MRsA-Zb0IQuxkCN_gxuhWGtOehNL73Um15600tDqcdeo3S-Wx_qFdk_ZRdoBC52AEaDbRPQGxd_uRwkKJlXI3e95Whs8e0o6GgceUPWBTK9tp37748fUeWJPw</recordid><startdate>20080815</startdate><enddate>20080815</enddate><creator>O’Connor, Stephen P.</creator><creator>Atwal, Karnail</creator><creator>Li, Chi</creator><creator>Liu, Eddie C.-K.</creator><creator>Seiler, Steven M.</creator><creator>Shi, Mengxiao</creator><creator>Shi, Yan</creator><creator>Stein, Philip D.</creator><creator>Wang, Ying</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20080815</creationdate><title>Synthesis and evaluation of acylguanidine FXa inhibitors</title><author>O’Connor, Stephen P. ; Atwal, Karnail ; Li, Chi ; Liu, Eddie C.-K. ; Seiler, Steven M. ; Shi, Mengxiao ; Shi, Yan ; Stein, Philip D. ; Wang, Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anticoagulants - chemical synthesis</topic><topic>Anticoagulants - pharmacology</topic><topic>Antithrombin III - chemical synthesis</topic><topic>Antithrombin III - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Carboxylic Acids - chemistry</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Coagulation</topic><topic>Drug Design</topic><topic>Factor Xa</topic><topic>Factor Xa - chemistry</topic><topic>Guanidines - chemical synthesis</topic><topic>Guanidines - pharmacology</topic><topic>Guanine - chemistry</topic><topic>Humans</topic><topic>Imidazoles - chemistry</topic><topic>Inhibitory Concentration 50</topic><topic>Medical sciences</topic><topic>Models, Chemical</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Serine protease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O’Connor, Stephen P.</creatorcontrib><creatorcontrib>Atwal, Karnail</creatorcontrib><creatorcontrib>Li, Chi</creatorcontrib><creatorcontrib>Liu, Eddie C.-K.</creatorcontrib><creatorcontrib>Seiler, Steven M.</creatorcontrib><creatorcontrib>Shi, Mengxiao</creatorcontrib><creatorcontrib>Shi, Yan</creatorcontrib><creatorcontrib>Stein, Philip D.</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O’Connor, Stephen P.</au><au>Atwal, Karnail</au><au>Li, Chi</au><au>Liu, Eddie C.-K.</au><au>Seiler, Steven M.</au><au>Shi, Mengxiao</au><au>Shi, Yan</au><au>Stein, Philip D.</au><au>Wang, Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of acylguanidine FXa inhibitors</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2008-08-15</date><risdate>2008</risdate><volume>18</volume><issue>16</issue><spage>4696</spage><epage>4699</epage><pages>4696-4699</pages><issn>0960-894X</issn><issn>0968-0896</issn><eissn>1464-3405</eissn><eissn>1464-3391</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>A series of acylguanidine derivatives were prepared and investigated as inhibitors of Factor Xa (FXa). These compounds were made by guanidine acylation with carboxylic acids using carbonyl diimidazole (CDI) as the coupling reagent. Conditions for the rapid synthesis and purification of these compounds are described along with their ability to inhibit FXa. The best FXa inhibitor is
1 with a FXa IC
50 of 6
nM.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18644722</pmid><doi>10.1016/j.bmcl.2008.07.004</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry, 2008-08, Vol.18 (16), p.4696-4699 |
issn | 0960-894X 0968-0896 1464-3405 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_19331450 |
source | ScienceDirect Journals |
subjects | Anticoagulants - chemical synthesis Anticoagulants - pharmacology Antithrombin III - chemical synthesis Antithrombin III - pharmacology Biological and medical sciences Blood Coagulation Blood. Blood coagulation. Reticuloendothelial system Carboxylic Acids - chemistry Chemistry, Pharmaceutical - methods Coagulation Drug Design Factor Xa Factor Xa - chemistry Guanidines - chemical synthesis Guanidines - pharmacology Guanine - chemistry Humans Imidazoles - chemistry Inhibitory Concentration 50 Medical sciences Models, Chemical Molecular Structure Pharmacology. Drug treatments Serine protease |
title | Synthesis and evaluation of acylguanidine FXa inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T04%3A34%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20acylguanidine%20FXa%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=O%E2%80%99Connor,%20Stephen%20P.&rft.date=2008-08-15&rft.volume=18&rft.issue=16&rft.spage=4696&rft.epage=4699&rft.pages=4696-4699&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2008.07.004&rft_dat=%3Cproquest_cross%3E19331450%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-1daed8cc98d9ad29d7aeb57bd6c0c3781623f8dd66f33136ecba94737ea11ff03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19331450&rft_id=info:pmid/18644722&rfr_iscdi=true |